Sun Yuan, Fujigaki Yoshihide, Sakakima Masanori, Hishida Akira
First Department of Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan.
Toxicol Appl Pharmacol. 2010 Feb 15;243(1):104-10. doi: 10.1016/j.taap.2009.11.018. Epub 2009 Nov 26.
Animals recovered from acute renal failure are resistant to subsequent insult. We investigated whether rats recovered from mild proximal tubule (PT) injury without renal dysfunction (subclinical renal damage) acquire the same resistance. Rats 14 days after recovering from subclinical renal damage, which was induced by 0.2 mg/kg of uranyl acetate (UA) (sub-toxic dose), were rechallenged with 4 mg/kg of UA (nephrotoxic dose). Fate of PT cells and renal function were examined in response to nephrotoxic dose of UA. All divided cells after sub-toxic dose of UA insult were labeled with bromodeoxyuridine (BrdU) for 14 days then the number of PT cells with or without BrdU-labeling was counted following nephrotoxic dose of UA insult. Rats recovered from subclinical renal damage gained resistance to nephrotoxic dose of UA with reduced renal dysfunction, less severity of peak damage (necrotic and TUNEL+ apoptotic cells) and accelerated PT cell proliferation, but with earlier peak of PT damage. The decrease in number of PT cells in the early phase of rechallenge injury with nephrotoxic UA was more in rats pretreated with sub-toxic dose of UA than vehicle pretreated rats. The exaggerated loss of PT cells was mainly caused by the exaggerated loss of BrdU+ divided cells. In contrast, accelerated cell proliferation in rats recovered from sub-toxic dose of UA was observed mainly in BrdU- non-divided cells. The findings suggest that rats recovered from subclinical renal damage showed partial acquired resistance to nephrotoxic insult. Accelerated recovery with increased proliferative activity of non-divided PT cells after subclinical renal damage may mainly contribute to acquired resistance.
从急性肾衰竭中恢复的动物对随后的损伤具有抗性。我们研究了从轻度近端小管(PT)损伤中恢复且无肾功能障碍(亚临床肾损伤)的大鼠是否获得了相同的抗性。大鼠在从由0.2mg/kg醋酸铀酰(UA)(亚毒性剂量)诱导的亚临床肾损伤中恢复14天后,再次接受4mg/kg的UA(肾毒性剂量)攻击。检测了肾毒性剂量的UA作用后PT细胞的命运和肾功能。在亚毒性剂量的UA损伤后,所有分裂细胞用溴脱氧尿苷(BrdU)标记14天,然后在肾毒性剂量的UA损伤后计数有或没有BrdU标记的PT细胞数量。从亚临床肾损伤中恢复的大鼠对肾毒性剂量的UA获得了抗性,肾功能障碍减轻,峰值损伤(坏死和TUNEL+凋亡细胞)的严重程度降低,PT细胞增殖加速,但PT损伤的峰值出现更早。在肾毒性UA再攻击损伤早期阶段,亚毒性剂量的UA预处理大鼠的PT细胞数量减少比载体预处理大鼠更多。PT细胞的过度损失主要是由BrdU+分裂细胞的过度损失引起的。相反,从亚毒性剂量的UA中恢复的大鼠中加速的细胞增殖主要在BrdU-未分裂细胞中观察到。这些发现表明,从亚临床肾损伤中恢复的大鼠对肾毒性攻击表现出部分获得性抗性。亚临床肾损伤后未分裂PT细胞增殖活性增加导致的加速恢复可能是获得性抗性的主要原因。